<?xml version="1.0" encoding="UTF-8"?>
<p id="para230">The primary endpoint was locally assessed and analysed as randomised in the assessable population, defined as all eligible patients who received at least one cycle of treatment and had an end of treatment scan or reported clinical progression as a reason for stopping trial treatment. A patient with no CT imaging but a report of clinical progression as reason for stopping trial treatment was categorised as having progressed.</p>
